 |
Studies Support Use of Prostate Cancer Prevention Drug
Recent research revealed that the drug finasteride, commonly used to treat enlarged prostates, decreases the risk of prostate cancer by nearly 25 percent. When the original results of the study, known as the Prostate Cancer Prevention Trial, were initially released in 2003, the good news was tempered by the fact that the study also revealed a small but statistically significant increase in the number of aggressive, high-grade prostate tumors in the men from the study who were taking finasteride. But two new analyses of the study's data show that finasteride decreases the risk of all types of prostate cancer, even for those men with high-grade tumors. |
 |
What's New at MSKCC.ORG
Multiple Myeloma Overview Updated
Multiple myeloma is a cancer of plasma cells -- a type of white blood cell that produces infection-fighting antibodies (immunoglobulins). In this newly expanded section, you can find information about symptoms, risk factors, diagnosis, treatment, and clinical trials, as well as our expertise in treating patients with multiple myeloma.
Bone Cancer Overview Updated
Bone cancer can present itself in any of the bones of the body, but it is diagnosed most often in the long bones of the arms and legs. This recently updated section includes information about our expertise in treating adults with bone cancer, as well as our services and research.
High School Students Visit Memorial Sloan-Kettering to Learn about Radiology
More than 60 high school students from New York City public schools traveled to Memorial Sloan-Kettering Cancer Center as part of Radiology: Giving Back to New York, an annual program designed to introduce New York City high school juniors to careers in radiology.
Staff Profile
An Interview with Xuejun Jiang
Cell biologist Xuejun Jiang's study of the fundamental processes of biology began in China when he was a college student and continued with graduate and postgraduate work in Texas.
Public Events
Survivorship: Living Beyond Cancer
On Tuesday, September 16, physicians from Memorial Sloan-Kettering Cancer Center will discuss the Center's survivorship initiative, including its programs, adult long-term survivorship care, tips to maximize good health after cancer, psychosocial aspects of survivorship, and more.
Unlocking the Mysteries of Cancer: A Conversation about Overall Wellness, Cancer Screening, Treatment, and Survivorship
On Tuesday, September 23, physicians from Memorial Sloan-Kettering Cancer Center, the Breast Examination Center of Harlem, and the Ralph Lauren Center for Cancer Care and Prevention will discuss the cancer continuum. The event will take place at the Adam Clayton Powell, Jr., State Office Building in Harlem, New York.
An Update on Brain and Spinal Cord Cancers
On Tuesday, October 21, physicians from Memorial Sloan-Kettering Cancer Center will discuss an overview of brain and spinal cord cancers, including risk factors, diagnosis, screening, treatment options, and support and follow-up care during and after treatment.
Cancer Information
Pancreatic Cancer: Treatment Updates and Future Directions Web Cast
Watch as Memorial Sloan-Kettering medical oncologist Eileen O'Reilly provides an overview on the challenges of treating pancreatic cancer, factors indicating genetic predisposition, symptoms, treatment options, and vaccine research.
Advances in the Treatment of Esophageal Cancer Web Cast
Watch as Memorial Sloan-Kettering radiation therapist Karyn Goodman provides an overview of esophageal cancer including the pathology of disease, risk factors, and treatment options, including PET-directed therapy, intensity-modulated radiation therapy (IMRT), and image-guided radiation therapy (IGRT).
Recommended Cancer-Related Information Resources
To help cancer patients and their families find the best, most reliable cancer-related online resources, Memorial Sloan-Kettering has created its Cancer-Related Resources on Other Web Sites.
Last Updated: Aug. 19, 2008
|
